View Older Stories View More Recent Stories

Feb 21, 2017 08:00AM Immunomedics Files Federal Lawsuit Against venBio for Continuing Material Violations of the Federal Securities Laws
Feb 15, 2017 05:26PM Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Feb 15, 2017 04:15PM Immunomedics Sends Letter to Stockholders Highlighting Value Creating Global Licensing Agreement, Underscoring Fulfillment of Promise to Stockholders
Feb 14, 2017 04:47PM Immunomedics Comments on Baseless venBio Lawsuit
Feb 14, 2017 04:02PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Feb 14, 2017 12:27PM Form 13F-HR venBio Select Advisor For: Dec 31
Feb 14, 2017 11:52AM venBio Takes Steps to Protect Immunomedics (IMMU) Stockholders Following Its Partnership with Seattle Genetics (SGEN)
Feb 14, 2017 11:50AM venBio Takes Steps to Protect Rights of Immunomedics Stockholders
Feb 13, 2017 03:28PM Form SC 13G/A Nabriva Therapeutics AG Filed by: venBio Global Strategic Fund II L.P.
Feb 10, 2017 05:16PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Feb 10, 2017 04:14PM venBio Comments on Immunomedics Partnership Announcement
Feb 9, 2017 05:00PM Form SC 13G AGENUS INC Filed by: venBio Select Advisor LLC
Feb 9, 2017 04:43PM Form SC 13G/A Lion Biotechnologies, Filed by: venBio Select Advisor LLC
Feb 9, 2017 04:41PM Form SC 13G/A Mirati Therapeutics, Filed by: venBio Select Advisor LLC
Feb 9, 2017 04:36PM Form SC 13G ALIMERA SCIENCES INC Filed by: venBio Select Advisor LLC
Feb 9, 2017 04:33PM Form SC 13G Oncobiologics, Inc. Filed by: venBio Select Advisor LLC
Feb 9, 2017 04:00PM Immunomedics Announces Second Quarter Fiscal 2017 Results and Clinical Program Developments
Feb 7, 2017 05:01PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Feb 7, 2017 12:45PM Immunomedics Strongly Encourages Stockholders to Reject the venBio Nominees — With Four New Independent Directors and a Robust Value-Maximization Process, Stockholders Should Not Risk Giving venBio
Feb 7, 2017 09:00AM Glass Lewis Endorses Full Slate of venBio Nominees at Immunomedics
Feb 6, 2017 05:02PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Feb 6, 2017 06:58AM ISS Endorses Full Slate of venBio Nominees at Immunomedics
Feb 2, 2017 04:15PM Immunomedics Mails Letter to Stockholders Highlighting Strength of New Board and Deep Engagement in Robust, Value-Creating Strategic and CMC Processes
Feb 2, 2017 02:25PM OrbiMed Comments on Immunomedics Proxy Contest
Feb 1, 2017 02:22PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 30, 2017 05:02PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 30, 2017 09:00AM Immunomedics Sets the Record Straight in New Presentation
Jan 30, 2017 09:00AM venBio Calls on Immunomedics Stockholders to Support Meaningful Change
Jan 27, 2017 07:00AM Immunomedics Issues Statement to Stockholders and Files Investor Presentation
Jan 26, 2017 08:11AM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 26, 2017 08:00AM venBio Releases Presentation Detailing Urgent Case for Change at Immunomedics
Jan 24, 2017 07:00AM Immunomedics Mails Letter to Stockholders
Jan 18, 2017 05:16PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 18, 2017 03:02PM venBio Sends Letter to Immunomedics Stockholders
Jan 12, 2017 07:00AM Immunomedics to Mail Letter to Stockholders Highlighting Unprecedented Progress Toward Enhanced Value Creation
Jan 11, 2017 05:09PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 11, 2017 09:25AM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 11, 2017 09:00AM venBio Sends Letter to Immunomedics Stockholders
Jan 10, 2017 05:17PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 10, 2017 08:00AM venBio Responds to Immunomedics Announcement
Jan 9, 2017 06:00AM Immunomedics Announces Reconstituted Board of Directors and Leadership Succession Plan
Dec 6, 2016 05:02PM Form DEFC14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Dec 2, 2016 05:30AM Impel NeuroPharma Announces $36M Funding to Advance Novel Drug Delivery Platform for Central Nervous System Disorders
Nov 29, 2016 04:11PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Nov 29, 2016 03:41PM Form PRRN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Nov 29, 2016 09:00AM venBio Responds to Immunomedics’ Postponement of Annual Meeting
Nov 28, 2016 07:03AM Immunomedics (IMMU) Announces Postponement of Annual Meeting of Stockholders
Nov 28, 2016 07:00AM Immunomedics Postpones 2016 Annual Meeting of Stockholders
Nov 22, 2016 03:08PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Nov 22, 2016 09:00AM venBio Comments on its Recent Nomination of Four Highly-Qualified Candidates for Board of Immunomedics, Inc.
View More Recent Stories View Older Stories